Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression (TalarAVN)

November 12, 2014 updated by: BG Trauma Center Ludwigshafen

Talar Avascular Necrosis: Surgical Angiogenesis Compared to Core Decompression With Osseous Autografting

The purpose of this study is to determine if surgical angiogenesis performed in talar avascular necrosis by free microvascular bone grafts from the medial femoral condyle is a superior technique compared to core decompression and nonvascularized osseous autografts.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The aim of this prospective randomized clinical trial is the comparison of two surgical treatment options for talar avascular necrosis (analogical to Ficat and Arlet stage II and III). The randomized study design allows direct comparability of the outcome after either core decompression and nonvascularized osseous autografting from the iliac crest or core decompression and osseous autografting with a free microvascular medial femoral condyle.

Talar avascular necrosis is caused by osseous malperfusion leading to malnutrition and destruction of the talar bone. The extend of this malperfusion is variable and can be categorized in 4 stages. The osseous defects can remain without consequences (stage I) or lead to irreversible talar destruction. The current treatment option for stage II and III is the core decompression followed by osseous auto grafting from the iliac crest. Reducing the intraosseal pressure and filling the drill holes with the nonvascularized bone graft can lead to reperfusion of the talus.

A new technique is to fill the drill hole with a vascularized bone graft from the medial femoral condyle, using microvascular anastomosis. This procedure has already been approved for the treatment of avascular necrosis and malperfusion of the carpus (lunate and scaphoid) as well as the femoral head.

Patients are examined preoperative as well as 3, 6 and 12 month after operation, documenting the active range of motion and pain sensation while resting and on activity. Well established scores like the AOFAS Ankle-Hindfoot Score and the Lower Extremity Functional Scale are used to get subjective and objective informations about patients' daily life and postoperative satisfaction. X-Rays are taken at the same stages. MRIs of the ankle joint with contrast agent are performed before as well as 6 and 12 months after surgery.

Statistical analysis is performed using the Statistical Package for the Social Sciences (SPSS). The Study protocol has been approved by the Ethics Commission of Rheinland-Pfalz. Interventions are done according to the declaration of Helsinki.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rheinland-Pfalz
      • Ludwigshafen, Rheinland-Pfalz, Germany, 67071
        • Recruiting
        • BG Trauma Center Ludwigshafen
        • Contact:
          • Victoria F Struckmann, MD
          • Phone Number: 0049-176-63158299
          • Email: vfs@me.com
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with talar avascular necrosis without response to non-surgical treatment (immobilization) and with need for surgical intervention (Ficat and Arlet stage II and III; Berndt and Harty stage II and III)

Exclusion Criteria:

  • talar avascular necrosis stage I (without need for surgical intervention)
  • surgical revascularization in the past
  • participation in a different study
  • pregnancy
  • peripheral artery occlusive disease
  • drug associated talar avascular necrosis
  • ongoing steroid therapy or chemo therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: femoral condyle
Core decompression of the talar avascular necrosis followed by free microvascular femoral condyle grafting
Drilling of the avascular necrosis of the talus by 10mm drill under x-ray control
Active Comparator: core decompression
Core decompression and nonvascularized autograft from the iliac crest
Drilling of the avascular necrosis of the talus by 10mm drill under x-ray control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain reduction
Time Frame: pre operation; 3, 6, 12 months post operation
measured by visual anloge scale
pre operation; 3, 6, 12 months post operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revascularization of the talus in the MRI
Time Frame: 6, 12 month post operation
by ARCO-Criteria
6, 12 month post operation
Lower Extremity Functional Scale
Time Frame: pre operation; 3, 6, 12 month post operation
pre operation; 3, 6, 12 month post operation
American Orthopaedic Foot and Ankle Society (AOFAS-) Ankle-Hindfoot-Score
Time Frame: pre operation; 3, 6, 12 month post operation
pre operation; 3, 6, 12 month post operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Thomas Kremer, Phd, MD, BG Trauma Center Ludwigshafen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Anticipated)

November 1, 2014

Study Completion (Anticipated)

November 1, 2016

Study Registration Dates

First Submitted

November 10, 2014

First Submitted That Met QC Criteria

November 12, 2014

First Posted (Estimate)

November 13, 2014

Study Record Updates

Last Update Posted (Estimate)

November 13, 2014

Last Update Submitted That Met QC Criteria

November 12, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Avascular Necrosis of Bone

Clinical Trials on core decompression

Subscribe